<DOC>
	<DOCNO>NCT01801150</DOCNO>
	<brief_summary>Aim : To assess six month treatment CPAP associate conventional drug therapy , contribute improve glycemic control patient type 2 diabetes sleep apnea-hypopnea syndrome SAHS )</brief_summary>
	<brief_title>CPAP Diabetes Type 2 Patients With Sleep Apnea</brief_title>
	<detailed_description>Main objective : To assess effect 6 month CPAP treatment associate conventional drug therapy glycemic control patient type 2 diabetes sleep apnea-hypopnea syndrome ( SAHS )</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>subject 18 75 year old ; diagnosis type 2 diabetes mellitus ; treatment diet ; oral antidiabetic insulin stable last month ; level HbA1c &gt; 7.5 % ( support clinic two control confirm difference exceed 0.5 % ) ; overweight obese ( BMI â‰¥ 25 kg/m2 ) professional driver , risk profession respiratory failure ; excessive daytime sleepiness high ( Epworth scale &gt; 18 ) ; morbid obesity ( BMI &gt; 40 kg/m2 ) ; CPAP treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Apnea- hypopnea Syndrome</keyword>
	<keyword>Glycemic control</keyword>
	<keyword>Prevalence</keyword>
	<keyword>SAHS</keyword>
	<keyword>life quality</keyword>
</DOC>